Lack of SATB2 expression has been reported as an adverse prognostic factor in sporadic CRCs, even in those harboring MMR-d, while it was associated with lymph node metastases in colitis-associated CRC [33,38,39,40]. This evidence concerns the gene SATB2 and colorectal carcinoma.